JP2024547113A5 - - Google Patents

Info

Publication number
JP2024547113A5
JP2024547113A5 JP2024537986A JP2024537986A JP2024547113A5 JP 2024547113 A5 JP2024547113 A5 JP 2024547113A5 JP 2024537986 A JP2024537986 A JP 2024537986A JP 2024537986 A JP2024537986 A JP 2024537986A JP 2024547113 A5 JP2024547113 A5 JP 2024547113A5
Authority
JP
Japan
Prior art keywords
methyl
crystal
characteristic peaks
oxetan
dihydrobenzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024547113A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/141418 external-priority patent/WO2023116882A1/zh
Publication of JP2024547113A publication Critical patent/JP2024547113A/ja
Publication of JP2024547113A5 publication Critical patent/JP2024547113A5/ja
Pending legal-status Critical Current

Links

JP2024537986A 2021-12-23 2022-12-23 Glp-1受容体作動薬の薬学的に許容される塩、結晶形及びその調製方法 Pending JP2024547113A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111584574.4 2021-12-23
CN202111584574 2021-12-23
PCT/CN2022/141418 WO2023116882A1 (zh) 2021-12-23 2022-12-23 一种glp-1受体激动剂的可药用盐、结晶形式及其制备方法

Publications (2)

Publication Number Publication Date
JP2024547113A JP2024547113A (ja) 2024-12-26
JP2024547113A5 true JP2024547113A5 (cg-RX-API-DMAC10.html) 2026-01-08

Family

ID=86901360

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537986A Pending JP2024547113A (ja) 2021-12-23 2022-12-23 Glp-1受容体作動薬の薬学的に許容される塩、結晶形及びその調製方法

Country Status (12)

Country Link
US (1) US20250049777A1 (cg-RX-API-DMAC10.html)
EP (2) EP4455141B1 (cg-RX-API-DMAC10.html)
JP (1) JP2024547113A (cg-RX-API-DMAC10.html)
KR (1) KR20240125003A (cg-RX-API-DMAC10.html)
CN (1) CN118434730A (cg-RX-API-DMAC10.html)
AU (1) AU2022418658A1 (cg-RX-API-DMAC10.html)
CA (1) CA3241670A1 (cg-RX-API-DMAC10.html)
DK (1) DK4455141T3 (cg-RX-API-DMAC10.html)
ES (1) ES3069025T3 (cg-RX-API-DMAC10.html)
MX (1) MX2024007906A (cg-RX-API-DMAC10.html)
TW (1) TW202328114A (cg-RX-API-DMAC10.html)
WO (1) WO2023116882A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4777197A2 (en) 2023-09-14 2026-07-22 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
WO2025109387A1 (en) 2023-11-24 2025-05-30 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
AU2025207498A1 (en) * 2024-01-09 2026-07-09 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Glp-1r agonist pharmaceutical composition and use thereof
TW202600132A (zh) 2024-03-08 2026-01-01 美商安尼波那生物公司 用於治療肥胖症及提高減重之方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3045644C (en) * 2018-06-13 2024-01-16 Pfizer Inc. Glp-1 receptor agonists and uses thereof
EA202191432A1 (ru) * 2018-11-22 2021-10-14 Цилу Регор Терапьютикс Инк. Агонисты glp-1r и их применения
WO2021249492A1 (zh) * 2020-06-10 2021-12-16 南京明德新药研发有限公司 甲基取代的苯并二噁唑类化合物及其应用
JP7812052B2 (ja) * 2020-09-01 2026-02-09 江蘇恒瑞医薬股▲ふん▼有限公司 縮合イミダゾール誘導体、その調製方法及びその医薬的応用
CN117177970A (zh) * 2021-04-30 2023-12-05 上海翰森生物医药科技有限公司 多环类衍生物调节剂、其制备方法和应用

Similar Documents

Publication Publication Date Title
RU2430099C2 (ru) Тозилатная соль терапевтического соединения и ее фармацевтические композиции
JPWO2022138988A5 (cg-RX-API-DMAC10.html)
JP2020059759A5 (cg-RX-API-DMAC10.html)
JP2009535340A5 (cg-RX-API-DMAC10.html)
JP2022008860A5 (cg-RX-API-DMAC10.html)
JP2017527578A5 (cg-RX-API-DMAC10.html)
JP5184511B2 (ja) 新しい結晶形態のラミブジン
BRPI0718546A2 (pt) Formas cristalinas de hemifumarato de alisquireno
JP2020528913A5 (cg-RX-API-DMAC10.html)
JP2024547112A5 (cg-RX-API-DMAC10.html)
WO2022133236A1 (en) Solid forms of a compound
JP2025508792A5 (cg-RX-API-DMAC10.html)
JP2024505063A5 (cg-RX-API-DMAC10.html)
JP2023530786A5 (cg-RX-API-DMAC10.html)
JP2022540678A5 (cg-RX-API-DMAC10.html)
JP2023530785A5 (cg-RX-API-DMAC10.html)
JP6748123B2 (ja) サクビトリルカルシウム塩
JP2024542840A5 (cg-RX-API-DMAC10.html)
KR100830002B1 (ko) 시부트라민의 무기산염
JP2024520897A5 (cg-RX-API-DMAC10.html)
AU2008332880B2 (en) Tosylate salt of trans-N-isobutyl-3-fluoro-3- [3-fluoro-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
US5574054A (en) Quaternary ammonium salts and use thereof as medicine
JP2021512910A5 (cg-RX-API-DMAC10.html)
JP2025531538A (ja) イナボグリフロジンの新規な共結晶
JP2021531338A5 (cg-RX-API-DMAC10.html)